FOXO3 and cancer: Moreover, doxorubicin, a potential drug which translocates the FOXO3A protein inside the cell nucleus [74], in combination with rapamycin, can prove to be a potential combination to diminish the proliferation of miR-21 induced cancer cell proliferation and could be a better template to study the oncogenic miR-21 pathway inactivation.